Veteran marijuana breeder James Loud is setting his sights on a niche that continues to grow: pre-rolls and ready-to-use joints. Over the next few years, he plans to develop plant varieties tailored for these products, with a focus on durability and consistency during storage and transport.
For manufacturers, longer-lasting marijuana that holds its quality in prepackaged form could offer a clear advantage. But for breeders like Loud, the challenge goes beyond cultivation. Safeguarding original work remains a persistent concern, particularly in a market where federal prohibition still complicates intellectual property protections.
Loud, founder of James Loud Genetics, relies on sophisticated breeding methods and tissue culture to create new strains. While federal law limits traditional protections, he has explored several legal avenues. These include plant variety protection through the Agriculture Department, as well as plant and utility patents issued by the U.S. Patent and Trademark Office (USPTO).
In practice, however, Loud often turns to private contracts. Licensing deals, commonly referred to as material transfer agreements, allow partners to grow his genetics under strict terms. Those agreements prohibit replication, limiting partners to cultivation only.
Legal experts caution that such contracts have limits. Dale Hunt, a San Diego intellectual property attorney, noted that these agreements depend on all parties honoring them. If plant material reaches someone outside the contract, enforcement becomes difficult, especially if that party is unaware of its origin.
Despite these hurdles, industry observers expect cannabis genetics to follow a path similar to other agricultural sectors.
Still, cannabis presents a more complicated case. Many modern strains build on genetics developed before legalization. That raises questions about whether early breeders can assert rights over their work in today’s regulated markets, particularly when competing against large, well-funded companies.
Recent developments overseas highlight the stakes. Aurora Cannabis, a Canadian producer, has secured plant variety rights in the European Union for two high-potency strains. According to observers, the move signals a shift toward formal protections for cannabis genetics on a global scale.
U.S. breeders, especially those who operated before legalization, may struggle to benefit financially if others secure rights first in international markets.
Aurora says its protected varieties can deliver significantly higher yields using the same resources, making them appealing to growers. The company plans to continue expanding its breeding efforts and licensing its genetics abroad, particularly as it shifts focus toward medical cannabis and international production, including operations in Germany.
In the U.S., federal restrictions still limit certain protections. The USDA’s plant variety program applies only to hemp, defined as cannabis containing no more than 0.3 percent THC. Securing such protection requires extensive testing to prove a plant’s distinct characteristics, uniformity, and stability, a process that can be costly and time-consuming.
For smaller breeders, those barriers can be difficult to overcome. Some are choosing to wait for clearer regulations, while others are moving forward with available tools, despite the risks.
Patent options remain available through the USPTO, though they come at a high price. A utility patent can cost tens of thousands of dollars, prompting breeders to weigh the commercial value of their creations against the expense and effort required to defend those rights.
As the cannabis sector continues to mature, more companies may adopt formal protections. For now, breeders must balance innovation with caution in an industry still defining its legal boundaries. Questions about evolving legal boundaries are also being faced by firms like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) and other licensed entities engaged in growing and selling marijuana products.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
